VICTOR MARMOLEJOS POLANCO: Open Payments
NPI 1225307085 · KISSIMMEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$254 in 14 payments from 8 companies in 2025. Trend: 2023 $283 · 2024 $288 · 2025 $254
Food & beverage: $254
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Lilly USA, LLC | 2 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $30 |
| Gilead Sciences, Inc. | 1 | $24 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: Ozempic, Kerendia, JARDIANCE, XIFAXAN, INSPIRE, REXULTI, KISUNLA.
Industry payments across FL — which companies pay providers there.
